Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TAM family receptors (Tyro3, Axl, Mer) are receptor tyrosine kinases that play critical roles in immune homeostasis, efferocytosis, hemostasis, and cell survival/proliferation. They are activated by ligands Gas6 and Protein S, which bind to their extracellular Ig-like domains, leading to receptor dimerization and activation of intracellular signaling pathways. Dysregulation of TAM receptors is implicated in various diseases, including autoimmune disorders, inflammation, thrombosis, and cancer.
Ligand binding (Gas6, Protein S) leading to receptor dimerization, autophosphorylation, and downstream signaling cascades.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TAM family receptors (TAM).